Access to COVID-19 Treatments for Persons Living with CLL
July 21 update
Evusheld available in New Brunswick, easier access to Paxlovid in Saskatchewan and New Brunswick
People with CLL are at greater risk of severe consequences of COVID-19 and less protected by vaccination because CLL reduces the effectiveness of their immune system. This document outlines the treatments that are available for COVID-19 to people with CLL and how to get access to them in each province.